Design, synthesis, and pharmacological characterization of some 2‐substituted‐3‐phenyl‐quinazolin‐4(3 H )‐one derivatives as phosphodiesterase inhibitors-Reference-Cited by-同舟云学术

Design, synthesis, and pharmacological characterization of some 2‐substituted‐3‐phenyl‐quinazolin‐4(3 H )‐one derivatives as phosphodiesterase inhibitors

Published:2021-05-11 Issue:9 Volume:354 Page:2100051
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Arch Pharm

Author:

Amin Kamilia M.¹,Hegazy Gehan H.¹,George Riham F.¹^ORCID,Ibrahim Nahla R.¹,Mohamed Nada M.²^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Cairo University Cairo Egypt

2. Department of Pharmaceutical Chemistry, Faculty of Pharmacy Modern University for Technology and Information MTI Cairo Egypt

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ardp.202100051

Reference62 articles.

1. Adenosine 3‘,5‘-Phosphate in Biological Materials

2. PDE inhibitors in psychiatry–future options for dementia, depression and schizophrenia?

3. Phosphodiesterase Inhibitors for Cognitive Enhancement

4. Phosphodiesterases in the CNS: targets for drug development

5. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases;European Journal of Medicinal Chemistry;2024-05

2. Design, synthesis, molecular docking, and molecular dynamic studies of novel quinazoline derivatives as phosphodiesterase 7 inhibitors;Frontiers in Pharmacology;2024-04-22

3. Advances in the development of phosphodiesterase 7 inhibitors;European Journal of Medicinal Chemistry;2023-03

4. Quinazolin-4(3H)-one based potential multiple tyrosine kinase inhibitors with excellent cytotoxicity;Journal of Enzyme Inhibition and Medicinal Chemistry;2021-01-01